Qualaquin (quinine sulfate) is not indicated for the prevention or treatment of nocturnal leg cramps.
Contra-indicated in patients with prolongation of QT interval, G6PD deficiency, myasthenia gravis, or optic neuritis.
- TRADE NAMES: Adaquin; Chinine; Formula-Q; Genin; M-KYA; Q-Vel; Qualaquin (URL Pharma); Quinoctal; Quinsan; Quinsul; Quiphile
- INDICATIONS: Malaria
- CLASS: Antimalarial, Antimicrobial, Antiprotozoal
- HALF-LIFE: 8–14 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amantadine, Amiodarone, Amitriptyline, Amoxapine, Anisindione, Anticoagulants, Arsenic, Artemether/Lumefantrine, Astemizole, Atazanavir, Atorvastatin, Cimetidine, Cisapride, Citalopram, Class Ia or III antiarrhythmics, Clevidipine, CYP3A4 and CYP2D6 substrates, CYP3A4 inducers or inhibitors, Darunavir, Dasatinib, Degarelix, Dicumarol, Digoxin, Disopyramide, Dofetilide, Dolasetron, Droperidol, Enalapril, Flecainide, Fosamprenavir, Halofantrine, Haloperidol, Histamine, Indinavir, Lapatinib, Levofloxacin, Mefloquine, Metformin, Moxifloxacin, Nelfinavir, Neuromuscular blocking agents, Olmesartan, Oral typhoid vaccine, Pazopanib, Pimozide, Procainamide, Prochlorperazine, Quinapril, Quinidine, Ramipril, Rifampin, Ritonavir, Saquinavir, Sotalol, Succinylcholine, Telavancin, Telithromycin, Terfenadine, Tipranavir, Voriconazole, Vorinostat, Warfarin, Ziprasidone
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
